The discovery of penicillin by Alexander Fleming in 1928 marked the beginning of the antibiotic era. Now a days antimicrobial resistance (AMR) is one of the growing global health concerns of today’s time. The antibiotics, we rely on slowly stop working and bacteria are becoming resistance to the medicines we use to treat them. While the world attracts most of the attention from viral outbreaks and the silent threat has been spreading quietly in hospital wards, livestock farms, and waterways for decades and if action is not taken promptly, the most ordinary medical conditions such as a surgery, a small cut and infection could become deadly.
AMR Crisis on a scale
Latest study of WHO’s 2025, confirmed that one in six bacterial infections were resistant to available antibiotic treatments between 2018 and 2023 (1). Resistance for more than 40% of bacteria-antibiotic combinations has been increased and that being monitored and that being increasing each year (2).
AMR directly caused 1.27 million deaths in 2019 and was associated with nearly five million more (3). A study of lancet 2024 tracking AMR trends since 1990 to 2021 projects direct death over 39 million between 2025 and 2050, with the heaviest burden in South Aisa and forecast to rise 146% deaths among aged people by 2050 (4)(5). Economic analyses estimate that antimicrobial resistance could reduce global GDP by approximately US$3 trillion annually by 2030 under high-resistance scenarios (2).
Major Causes of Antibiotic Resistance
The roots of the resistance crisis lie in the misuse of antibiotics in healthcare and overuse in agriculture and a lack of innovation in antibiotic development.
Overprescription and misuse remain the most direct drivers. Antibiotics are frequently prescribed for viral infections colds, flu, most sore throats against which they are entirely ineffective. Unnecessary antibiotic exposure, inappropriate prescribing, and poor adherence to treatment all contribute to resistance.
Livestock farming accounts: Large proportion of global antibiotic consumption drugs are routinely administered not only to treat sick animals, but to promote growth and prevent disease in crowded conditions. Resistant bacteria from farms enter the food chain, spread through waterways, and could reach human populations through multiple pathways.
Broken drug pipeline: Urge of developing new antibiotics are increasing because existing antibiotics are resistance to inhibit bacterial growth. But developing new antibiotics is time-consuming and costly since doctors prescribe these antibiotics to use for severe. Consequently, newly developed antibiotics are reserved for severe infections to preserve their effectiveness. Approximately 18 novel antibiotics received regulatory approval between 2014 and 2024.
Antibiotic Resistance on bacterial strains
WHO reports that Gram negative bacteria are harder to kill due to its double-membrane cell envelope and acquire resistance quickly. Over 40% of E. coli strains and 55% of K. pneumoniae strains now resist first-line treatments globally. There are certain bacteria on which no longer antibiotics work, such (MRSA), carbapenem-resistant Acinetobacter baumannii, and multi-drug-resistant tuberculosis are commonly found in hospitals, communities, and care homes and for some patients, there is already no effective treatment left (2).
Emerging Strategies Against AMR:
- Phage Therapy: Unlike broad-spectrum antibiotics, phage selectively eliminate target bacteria while preserving beneficial microorganisms. Bacteriophages are abundant in the human microbiome. Phage therapy is increasingly being investigated, a recent study of Nature microbiology 2024, tested on 100 patients, from which 77% got better and bacteria was eliminated in 61% in the observational study (6). Phage exquisitely target a specific bacterial strain without disturbing the body’s beneficial microbiome. Phage therapy is currently being evaluated in clinical trials worldwide.
- Artificial Intelligence- Accelerating the Hunt for New Drugs: Developing a new antibiotic typically requires 10-15 years and substantial financial investment in R&D, however the advances in the AI transforming the whole process, now using machine learning algorithms can analyse the vast molecular libraries to identify compound with antibiotic potential. Generative AI models are paving the way to design completely new antibiotic molecules from scratch [7].
- Vaccines and Microbiome Science: Vaccines against bacterial pathogens including Staphylococcus aureus and Klebsiella pneumoniae are in development, offering the prospect of preventing resistant infections before they take hold (8). The new era of microbiome science where the good gut bacteria resist the harmful bacteria to colonise and leading to probiotic-based prevention strategies
- Policy and Stewardship: Expanding antimicrobial stewardship programmes, improving diagnostic testing, and strengthening surveillance systems are essential for preserving antibiotic effectiveness. The general assembly of United Nations set a goal to decrease the 10% AMR related deaths by 2030, this will require strict action to regulate the use of antibiotics and effective implementation of programmes. Avoid prescribing antibiotics for viral infection and proper diagnostic testing is required to distinguish bacterial infections from viral ones ensuring that antibiotics are used only when necessary.
A Collective Responsibility
Antibiotics remain one of the greatest achievements in modern medicine. Preserving their effectiveness will require coordinated action from governments, healthcare professionals, researchers, farmers, and the public. The choices made today will determine whether future generations continue to benefit from these life-saving medicines. The emergence of resistance in bacteria once easily treated with penicillin illustrates how quickly microorganisms can adapt to antibiotic pressure.
Over the past century, antibiotics that have saved millions of lives have stopped showing effective results the way they used to show. They are a resource borrowed from nature; and bacteria continue to evolve in response to antibiotic exposure, reducing the effectiveness of medicines that transformed twentieth-century healthcare. How we respond to that demand will define the medicine of the next century.
References
- https://www.paho.org/en/news/13-10-2025-who-warns-widespread-resistance-common-antibiotics-worldwide
- doi:10.1016/S0140-6736(24)01867-1
FAQs
1. Can my body become resistant to antibiotics?
No. It is the bacteria, not your body that become resistant. When resistant bacteria infect you, the antibiotics that previously worked may no longer be effective.
2. Why don’t antibiotics work against viral infections?
Antibiotics target bacteria, whereas viruses have completely different biological structures. Illnesses such as influenza, COVID-19, and most sore throats and common colds are caused by viruses, so antibiotics provide no benefit and unnecessary use only increases resistance.
3.Does antibiotic use in animals affect human health?
Yes. Antibiotics are widely used in livestock to treat disease and, in some regions, to prevent infections or promote growth. Resistant bacteria can spread from animals to humans through food, direct contact, or environmental contamination such as water and soil.
4. How are hospitals combating AMR?
Hospitals implement antimicrobial stewardship programmes that promote appropriate antibiotic prescribing, infection prevention, rapid diagnostic testing, surveillance of resistant bacteria, and strict hygiene practices to limit the spread of resistant infections.